Hemogenyx Pharmaceuticals Plc Shareholders' Equity for the year ending December 31, 2022: USD 3.96 M

Hemogenyx Pharmaceuticals Plc Shareholders' Equity is USD 3.96 M for the year ending December 31, 2022. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Hemogenyx Pharmaceuticals Plc Shareholders' Equity for the year ending December 31, 2020 was USD 1.22 M, a -364.96% change year over year.
  • Hemogenyx Pharmaceuticals Plc Shareholders' Equity for the year ending December 31, 2019 was USD -459.14 K.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory